As of August 28, 2026, Galmed Pharmaceuticals Ltd. (GLMD) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. Galmed Pharmaceuticals Ltd. has a market capitalization of $4.97M, 6.58M shares outstanding, 10 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.62 below $1 exchange minimum
Market Data
Market Cap$4.97M
Shares Outstanding6.58M
Float6.37M
Cash$10.98M
DebtN/A
Short InterestN/A
Institutional Holdings
10 institutional holders · 221.6K shares
#1
Two Sigma Investments, LP
112.1K shares
#2
Citadel Advisors Llc
38.2K shares
#3
Two Sigma Advisers, LP
31.5K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest147.0K
Days to Cover1.0
% of Float2.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2015-12-31
EFFECT
EFFECT
2026-04-01
3
FORM3
2026-03-18
3
FORM3
2026-03-18
3
FORM3
2026-03-18
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual GLMD Dilution Snapshot
Galmed Pharmaceuticals Ltd. (GLMD) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for GLMD: EFFECT on 2026-04-01; 3 on 2026-03-18; 3 on 2026-03-18.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track GLMD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GLMD — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for GLMD
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.